tiprankstipranks
Peak Bio, Akari Therapeutics announce portfolio prioritization plan
PremiumThe FlyPeak Bio, Akari Therapeutics announce portfolio prioritization plan
3M ago
Akari Therapeutics, Peak Bio announce portfolio prioritization plan
PremiumThe Fly
Akari Therapeutics, Peak Bio announce portfolio prioritization plan
3M ago
Akari CEO Jacques, COO Bradford-Klug step down, appoints Patel as interim CEO
PremiumThe Fly
Akari CEO Jacques, COO Bradford-Klug step down, appoints Patel as interim CEO
3M ago
Akari Therapeutics, Peak Bio announce definitive agreement to merge as equals
PremiumThe FlyAkari Therapeutics, Peak Bio announce definitive agreement to merge as equals
5M ago
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
PremiumPress Releases
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
5M ago
Akari Therapeutics issues 947,868 ADSs at $2.11 in private placement
PremiumThe Fly
Akari Therapeutics issues 947,868 ADSs at $2.11 in private placement
7M ago
Akari Therapeutics files to sell 1.285B ordinary shares for holders
PremiumThe FlyAkari Therapeutics files to sell 1.285B ordinary shares for holders
9M ago
Akari Therapeutics Reports First Half 2023 Financial Results and Highlights
PremiumPress Releases
Akari Therapeutics Reports First Half 2023 Financial Results and Highlights
10M ago
Akari Therapeutics expects cash to fund operations into 1Q24
PremiumThe Fly
Akari Therapeutics expects cash to fund operations into 1Q24
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100